berberine has been researched along with oxidopamine in 18 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 10 (55.56) | 18.2507 |
| 2000's | 3 (16.67) | 29.6817 |
| 2010's | 5 (27.78) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Huang, KX; Jin, GZ; Sun, BC | 1 |
| Harsing, LG; Vizi, ES | 1 |
| Jin, GZ; Sun, BC; Zhang, XX | 1 |
| Chen, LJ; Creese, I; Dong, ZJ; Jin, GZ | 1 |
| Jin, GZ; Liu, J; Zou, LL | 1 |
| Ding, YM; Guo, X; Hu, JY; Jin, GZ | 1 |
| Jin, GZ; Zhang, XX; Zhu, ZT | 1 |
| Guo, X; Jin, GZ; Jin, J; Liu, J; Wang, BC; Zou, LL | 1 |
| Fu, Y; Hu, GY; Jin, GZ; Liu, J; Zhang, XX | 1 |
| Fu, Y; Jin, GZ; Wu, WR; Zhu, ZT | 1 |
| Ding, YM; Fu, Y; Jin, GZ; Tang, FM; Yu, LP; Zhang, GY | 1 |
| Fu, Y; Hu, GY; Jin, GZ; Zhu, ZT | 1 |
| Guo, X; Jin, GZ; Liu, J; Wang, BC | 1 |
| Jin, GZ; Mo, J; Sun, PH; Yu, LP; Zhang, H; Zhen, X | 1 |
| Choi, HS; Hwang, BY; Kwon, IH; Lee, BK; Lee, CK; Lee, MK; Lim, SC; Shin, KS | 1 |
| Bae, J; Gil, M; Kim, YK; Lee, D; Lee, JY; Lee, KJ | 1 |
| Choi, HS; Choi, SO; Kwon, IH; Lee, MK; Shin, KS; Suh, KH; Zhao, TT | 1 |
| Bao, J; Chen, M; Chen, S; He, C; Jia, X; Lee, SMY; Li, C; Li, P; Li, Z; Liang, Y; Liu, K; Su, H; Wan, JB; Wang, K; Wang, X; Zhang, C | 1 |
18 other study(ies) available for berberine and oxidopamine
| Article | Year |
|---|---|
Dual actions of (-)-stepholidine on dopamine receptor subtypes after substantia nigra lesion.
Topics: Animals; Apomorphine; Berberine; Dopamine Antagonists; Male; Oxidopamine; Rats; Rats, Sprague-Dawley; Receptors, Dopamine; Stereoisomerism; Stereotyped Behavior; Substantia Nigra; Tetrahydronaphthalenes; Thiophenes | 1992 |
Alpha 2-adrenoceptors are not involved in the regulation of striatal glutamate release: comparison to dopaminergic inhibition.
Topics: 4-Butyrolactone; Animals; Apomorphine; Berberine; Chromatography, High Pressure Liquid; Corpus Striatum; Dopamine; Drug Interactions; Glutamates; Glutamic Acid; Haloperidol; Hydrazines; Hydroxydopamines; Male; Oxidopamine; Potassium Chloride; Rats; Rats, Inbred Strains; Receptors, Adrenergic, alpha; Secretory Rate; Synaptic Transmission; Yohimbine | 1991 |
(-)-Stepholidine acts as a D1 partial agonist on firing activity of substantia nigra pars reticulata neurons in 6-hydroxydopamine-lesioned rats.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Apomorphine; Benzazepines; Berberine; Dopamine Agonists; Electrophysiology; Haloperidol; Male; Membrane Potentials; Microelectrodes; Neurons; Oxidopamine; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Reserpine; Substantia Nigra | 1996 |
GTP regulation of (-)-stepholidine binding to R(H) of D1 dopamine receptors in calf striatum.
Topics: Adenylyl Cyclases; Animals; Apomorphine; Benzazepines; Berberine; Binding, Competitive; Cattle; Corpus Striatum; Guanosine Triphosphate; Male; Oxidopamine; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Rotation; Spiperone | 1997 |
Involvement of receptor reserve in D1 agonistic action of (-)-stepholidine in lesioned rats.
Topics: Adenylyl Cyclases; Animals; Apomorphine; Berberine; Corpus Striatum; Dopamine; Dose-Response Relationship, Drug; Male; Oxidopamine; Quinolines; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Rotation | 1997 |
Involvement of dopamine D1 and D2 receptors in Fos immunoreactivity induced by stepholidine in both intact and denervated striatum of lesioned rats.
Topics: Animals; Berberine; Corpus Striatum; Denervation; Dopamine Agonists; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Horseradish Peroxidase; Immunohistochemistry; Male; Nerve Tissue Proteins; Oxidopamine; Proto-Oncogene Proteins c-fos; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Reference Values | 1998 |
Comparison of (-)-stepholidine and D1 or D2 agonists on unit firing of globus pallidus in 6-hydroxydopamine-lesioned rats.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Benzazepines; Berberine; Calcium Channel Blockers; Dopamine Agonists; Dopamine Antagonists; Drug Interactions; Globus Pallidus; Male; Neurons; Oxidopamine; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Receptors, Dopamine D2 | 1998 |
Enhancement of (-)-stepholidine on protein phosphorylation of a dopamine- and cAMP-regulated phosphoprotein in denervated striatum of oxidopamine-lesioned rats.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Benzazepines; Berberine; Corpus Striatum; Dopamine Agonists; Dopamine and cAMP-Regulated Phosphoprotein 32; Dopamine Antagonists; Enzyme Inhibitors; Male; Nerve Tissue Proteins; Oxidopamine; Phosphoproteins; Phosphorylation; Rats; Rats, Sprague-Dawley | 1998 |
Action sites of rotation and unit firing induced by l-stepholidine and DA agonists in basal ganglia of 6-OHDA-lesioned rats.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Apomorphine; Berberine; Dopamine Agonists; Dopamine Antagonists; Electrophysiology; Male; Neostriatum; Oxidopamine; Rats; Rats, Sprague-Dawley; Rotation; Substantia Nigra | 1999 |
I-stepholidine facilitates inhibition of mPFC DA receptors on subcortical NAc DA release.
Topics: Animals; Berberine; Dopamine; Male; Microinjections; Neurons; Nucleus Accumbens; Oxidopamine; Prefrontal Cortex; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1 | 2000 |
Relevance between striatal expression of Fos, proenkephalin mRNA, prodynorphin mRNA and rotation induced by l-stepholidine in 6-hydroxydopamine-lesioned rats.
Topics: Animals; Berberine; Dopamine Antagonists; Enkephalins; Gene Expression; Genes, fos; Oxidopamine; Protein Precursors; Rats; Rats, Sprague-Dawley; RNA, Messenger; Rotation | 2000 |
Electrophysiological study on biphasic firing activity elicited by D(1) agonistic-D(2) antagonistic action of (-)-stepholidine in nucleus accumbens.
Topics: Animals; Berberine; Dopamine D2 Receptor Antagonists; Electrophysiology; Male; Neurons; Nucleus Accumbens; Oxidopamine; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1 | 2000 |
Increased phosphorylation of DARPP-32 by D1 agonistic action of l-stepholidine in the 6-OHDA-lesioned rat striatum.
Topics: Animals; Berberine; Corpus Striatum; Dopamine Agonists; Dopamine and cAMP-Regulated Phosphoprotein 32; Male; Nerve Tissue Proteins; Oxidopamine; Phosphoproteins; Phosphorylation; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Signal Transduction | 1999 |
L-stepholidine reduced L-DOPA-induced dyskinesia in 6-OHDA-lesioned rat model of Parkinson's disease.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Analysis of Variance; Animals; Antiparkinson Agents; Antipsychotic Agents; Benzazepines; Berberine; CHO Cells; Corpus Striatum; Cricetinae; Cricetulus; Disease Models, Animal; Dopamine Agents; Drug Administration Schedule; Drug Interactions; Dyskinesias; Gene Expression Regulation; Levodopa; Male; Oxidopamine; Parkinsonian Disorders; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT1A; RNA, Messenger; Serotonin Receptor Agonists; Transfection; Tritium | 2010 |
Effects of berberine on 6-hydroxydopamine-induced neurotoxicity in PC12 cells and a rat model of Parkinson's disease.
Topics: Animals; Berberine; Cell Death; Corpus Striatum; Disease Models, Animal; Dopamine; Dose-Response Relationship, Drug; Drug Synergism; Male; Neurotoxicity Syndromes; Norepinephrine; Oxidopamine; Parkinsonian Disorders; PC12 Cells; Rats; Rats, Sprague-Dawley; Substantia Nigra; Tyrosine 3-Monooxygenase | 2010 |
Berberine protects 6-hydroxydopamine-induced human dopaminergic neuronal cell death through the induction of heme oxygenase-1.
Topics: Berberine; Cell Death; Cell Line, Tumor; Cell Nucleus; Dopaminergic Neurons; Gene Expression Regulation; Heme Oxygenase-1; Humans; Neuroprotective Agents; NF-E2-Related Factor 2; Oxidopamine; Protein Transport; Signal Transduction | 2013 |
Neurotoxic effects of berberine on long-term L-DOPA administration in 6-hydroxydopamine-lesioned rat model of Parkinson's disease.
Topics: Animals; Antiparkinson Agents; Berberine; Dopamine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Levodopa; Male; Neurons; Neurotoxicity Syndromes; Oxidopamine; Parkinsonian Disorders; Rats; Rats, Sprague-Dawley; Substantia Nigra; Time Factors | 2013 |
Berberine protects against 6-OHDA-induced neurotoxicity in PC12 cells and zebrafish through hormetic mechanisms involving PI3K/AKT/Bcl-2 and Nrf2/HO-1 pathways.
Topics: Animals; Antioxidants; Apoptosis; Berberine; Cell Survival; Disease Models, Animal; Dopaminergic Neurons; Heme Oxygenase-1; Hormesis; Humans; Neuroprotective Agents; NF-E2-Related Factor 2; Oncogene Protein v-akt; Oxidopamine; Parkinson Disease, Secondary; PC12 Cells; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-bcl-2; Rats; Reactive Oxygen Species; Signal Transduction; Zebrafish | 2017 |